63539-051 : Talzenna .5 mg Oral Capsule
NDC: | 63539-051 |
Labeler: | U.S. Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Talzenna |
Dosage Form: | Oral Capsule |
Application #: | NDA211651 |
Rev. Date: |
NDC Package Codes:
- 63539-051-30: 1 BOTTLE IN 1 CARTON (63539‑051‑30) / 30 CAPSULE IN 1 BOTTLE
Active Ingredients:
- Talazoparib Tosylate
Dosage Strength:
- .5 mg
Pharmaceutical Classes:
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
- Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 63539-295 Talzenna 1 mg Oral Capsule by U.S. Pharmaceuticals
- 0069-0296 Talzenna .25 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-1031 Talzenna .1 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-1195 Talzenna 1 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-1235 Talzenna .35 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-1501 Talzenna .5 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-1751 Talzenna .75 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 63539-044Next: 63539-112 >
Related Discussions:
How many people in USA using Sorafenib Tosylate?
Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can... 2 replies
Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.